Tuesday, November 10, 2009
The wanton disregard for humanity in the quest for profits is disgusting. J&J is no different than street corner drug dealers, except they operate under the cover of a "corporation". Just take a look at the picture above...
I DO NOT UNDERSTAND WHY THERE IS NO CRIMINAL INVESTIGATION INTO THE PATTERN OF REALLY BAD CORPORATE BEHAVIOR OF J&J. MAYBE THERE IS AND WE DON'T KNOW IT.
They certainly offer no relief of any kind to "externalities", those they know they are going to harm. They just do not know the names or the faces of those they know they will harm. Those nifty little package inserts sealed in the sterile packaging of their medical devices with all those disclaimers protect them legally in almost all instances.
Of course, their billions of dollars of profit also protect them, as it is virtually impossible to win in a lawsuit for the harm they cause.
See excerpts from the RPM Report below which may be the beginnings of those investigations, we can only hope:
Monday, November 09 2009 - Omnicare Settles Long Term Care Kickback Case; Is J&J the Real Target? By Michael McCaughan
"In an era of billion dollar fraud settlements, a $98 million settlement with Omnicare and an even smaller agreement with Ivax may seem like small potatoes. But prosecutors still have some big fish on the hook, including Johnson & Johnson....Here is what J&J says specifically about the Omnicare investigation:
In September 2005, the Company received a subpoena from the U.S. Attorney's Office, District of Massachusetts, seeking documents related to sales and marketing of eight drugs to Omnicare, Inc., a manager of pharmaceutical benefits for long-term care facilities. The Johnson & Johnson subsidiaries involved responded to the subpoena. Several employees of the Company's pharmaceutical subsidiaries have been subpoenaed to testify before a grand jury in connection with this investigation.
In April 2009, the Company was served with the complaints in two civil qui tam cases relating to marketing of prescription drugs to Omnicare, Inc. The complaints assert claims under the federal False Claims Act and related state statutes in connection with the marketing of several drugs to Omnicare. The government has not yet announced whether it will intervene in these cases."
"But that is not the only investigation involving Risperdal disclosed by J&J. The company's 10-Q filing cites at least 8 other subpoenas received by the company involving promotions of the product:
(1) a January 2004 subpoena seeking information about "sales and marketing of, and clinical trials for" from the Office of Personnel Management (which runs the Federal Employee Health Benefit Program);
(2) a November 2005 subpoena seeking information about "marketing of and adverse reactions to" Risperdal from the Philadelphia US Attorney (which brought the Zyprexa case);
(3) grand jury "subpoenas" related to that investigation;
(4-6) three separate subpoenas from the feds in Boston, Philadelphia and San Francisco "concerning, respectively, sales and marketing of Risperdal by Janssen (now OMJPI), Topamax by Ortho-McNeil (now OMJPI) and Natrecor by Scios" seeking "information regarding the Company's corporate supervision and oversight of these three subsidiaries, including their sales and marketing of these drugs";
(7) grand jury "subpoenas" in Boston related to those investigations; and
(8) a "HIPPA Subpoena" from Boston a "seeking information regarding the Company's financial relationship with several psychiatrists."
That tally does not include product liability cases (including some filed by state and federal government payors) involving Risperdal, nor does it include numerous pricing cases that presumably involve Risperdal as well.
We have no idea when or if any of those cases will result in prosecutions or settlements. But if they do, we're betting there will be some big numbers on the table."
MEANWHILE…..FROM PHARMALOT.COM …
Weldon Pays $8.5M For Florida Lots As J&J Cuts Jobs
By Ed Silverman November 3rd, 2009 // 3:07 pm
Just a week before announcing that Johnson & Johnson will cut some 8,000 jobs, J&J chair and chief executive Bill Weldon plunked down $8.45 million for two adjacent vacant waterfront lots in North Palm Beach, Fl., and he bought them from former General Electric chair and chief executive Jack Welch, according to The Palm Beach Daily News and brought to our attention by Bnet.
The properties are listed as 1264 Lake Worth Lane in Lost Tree Village with 113 feet of water frontage for $2.975 million and 1284 Lake Worth Lane, with 111 feet of frontage, for $5 million, according to the Property Appraiser’s Office records, the paper writes. Several realtors advertise exclusive properties in the enclave.
One of the realtors has this to say: “Lost Tree…is known for its Ocean, intracoastal, golf course, and lake views…There are homes on Lake Worth with wide water views and deep water ocean access, golf cottages located near the private golf course, and homes on interior lakes in this beautiful community. Lost Tree offers a private 18 hole golf course, 8 tennis courts, private beach…a beautiful beach club with a private restaurant open 2 days a week for dinner and for lunches most of the year.”
As for J&J employees? Some will be canvassing severance packages, COBRA health plans and, possibly, unemployment benefits. “These types of changes are difficult under any circumstances, and will have a very personal impact on people who have been dedicated to the mission of Johnson & Johnson,” Weldon says in today’s statement about the reorganization. Well, if nothing else, he’s stimulating the economy, albeit a well-to-do pocket.
MY THOUGHTS ON CEO WELDON’S PURCHASES….
For what it’s worth, all those $8.5 million after tax dollars Weldon is spending is on the backs of thousands and thousands of injured patients.
Johnson & Johnson spends millions and millions of dollars paying legions of attorneys to continue to make their billions of dollars in profit. Don’t believe me check out the Pacer System and do a search on J&J…literally hundreds of cases at any given time.
Think…Panacryl sutures, Ortho Evra patches, Prolene mesh, Intergel adhesion preventive…they will put anything on the market…deadly or not.
Just ask their Dr. Joel Lippman, their ex-Chief Medical Oficer, who tried to stop some of these products from going on the market.
If they were spending ANY of that money on the “externalities”, as they call injured patients, God bless Weldon.
As that is not the case, I am not sending any blessings Weldon’s way.